Abstract
A study was conducted focusing on 1) the shift of the CP 'cap' (CPA-dependent survival barrier) through the use of HTS as a CPA carrier and 2) the molecular activation of the apoptotic caspase cascade following CP in human fibroblast, kidney, and liver cell lines. Cells were subjected to a controlled rate freezing protocol in media or HTS containing 0-20% DMSO. Post-thaw viability was assessed using a metabolic indicator, alamarBlue, and a DNA stain, SytoDye. Caspase expression following CP was investigated by RT-PCR analysis. Results show that 1) CP results in a survival 'cap,' 2) HTS 'lifts' the CP 'cap' and allows for a reduction in DMSO, 3) gene activation occurs following CP, and 4) the control of CP-induced gene activation may increase CP effectiveness.
| Original language | English |
|---|---|
| Pages (from-to) | S-124 |
| Journal | Annals of Biomedical Engineering |
| Volume | 28 |
| Issue number | SUPPL. 1 |
| State | Published - 2000 |
| Event | 2000 Annual Fall Meeting of the Biomedical Engineering Society - Washington, WA, USA Duration: Oct 12 2000 → Oct 14 2000 |
Fingerprint
Dive into the research topics of 'Lifting the cryopreservation 'cap': improved survival and CPA reduction through molecular biological analysis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver